IDDO’s team looks forward to sharing its latest research at ASTMH

Join IDDO and WWARN’s researchers at this year’s American Society of Tropical Medicine & Hygiene (ASTMH) in where we will be presenting on Visceral Leishmaniasis, malaria, COVID-19 and across symposia, oral presentations and posters.

ASTMH 2024 logo

Taking place in New Orleans, USA, this year IDDO will be at stand #104, as part of the Centre for Tropical Medicine and Global Health, University of Oxford. Come and see us to find out about more about our research, data platforms and latest work.

IDDO’s team is hosting a symposium titled: ‘Improving the diagnosis and management of severe malaria’. Taking place on Saturday, November 16, at 8am (CST), the symposium will be chaired by IDDO’s Associate Director Dr James Watson and Dr Elizabeth George, who heads up the WWARN Severe Malaria theme, with presentations by:

  • Dr Peter Olumese (WHO) - The need to update WHO guidelines around severe malaria
  • Dr Elizabeth George - Management of patients with severe malaria and the need for randomized trials in Africa 
  • Dr James Watson - Improving the diagnosis and triage of patients with suspected severe malaria
  • Prof Sir Nick White - Pre-referral treatment for severe malaria
  • Prof Arjen Dondorp - Pathophysiology of severe malaria: updates
  • Prof Kamija Phiri - Post-discharge malaria chemoprevention: from policy to practice

IDDO’s talks include Dr James Wilson, who will talk about his work, ‘Peering into the Crystal Ball - Predicting Outcomes in Visceral Leishmaniasis, in Scientific Session 128: Clinical Tropical Medicine: Neglected Tropical Diseases’, on Saturday, November 16, at 12.45pm (CST).

While Dr Prabin Dahal will present his work, Severe Anaemia and Haemoglobin Trajectory following Treatment of Visceral Leishmaniasis: An Individual patient data meta-analysis using the Infectious Diseases Data Observatory Data Platform, in Scientific Session 168 on Sunday, November 17, at 8am (CST).

Our collaborators will also be presenting their work, look out for:

Professor Joel Tarning, head of WWARN Pharmacometric Modelling and Head of Clinical Pharmacology at MORU Bangkok, will present his latest work in symposium: Neglected tropical diseases: Getting the dose right, on Thursday Nov 14, from 10.15am (CST) in room 357.

PARMA Symposium #62, organised by the Malaria Branch, Centers for Disease Control & Prevention, titled Falling Dominoes: Antimalarial Resistance Proliferation in East and Central Africa. It takes place on Friday, November 15, from 10.15am (CST) at the Convention Center Hall I-2 (first floor)

Professor Joel Tarning will give a rapid oral talk on: Pharmacokinetic and Pharmacodynamic Modeling of Monthly Tafenoquine in Healthy Vietnamese Volunteers for Malaria Prophylaxis and Elimination on Friday Nov 15, from 10.15am (CST) in room 393/394. This will also be in poster session C on Saturday, November 16.

 

IDDO and WWARN’s researchers are also presenting a number of posters at ASTMH

 

Poster Session A: Thursday, November 14, Noon – 1:45 pm (CST) 

  • Professor Joel Tarning: Group Dose-optimisation of the fixed-dose triple combination antimalarial therapy artemether-lumefantrine-amodiaquine
  • Professor Joel Tarning: Ivermectin and Anopheles Glutamate-Gated Chloride Ion Channel Interactions
  • Professor Joel Tarning: Pre-referral rectal artesunate in children with severe malaria: any benefit? 
  • Poster Session B, Friday, November 15, Noon – 1:45 pm (CST)
  • Professor Joel Tarning: Pharmacokinetic properties and mosquito-lethal effects of a novel long-lasting formulation of ivermectin in cattle
  • Professor Joel Tarning: Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria

 

Poster Session C, Saturday, November 16, 11 am – 12:45pm (CST)

  • Dr Prabin Dahal: Factors associated with Relapse in Visceral Leishmaniasis: An Individual Patient Data Meta-Analysis using the Infectious Diseases Data Observatory Data Platform #8191
  • Professor Joel Tarning: Pharmacokinetic and Pharmacodynamic Modeling of Monthly Tafenoquine in Healthy Vietnamese Volunteers for Malaria Prophylaxis and Elimination
  • Dr Prabin Dahal: Exploring the Impact of Randomised Controlled Trials Evaluating COVID-19 Therapeutics on Clinical Practice Guidelines

 

ASTMH takes place from November 13 to 17, at the Ernest N. Morial Convention Center, New Orleans, where thousands of researchers, scientists, physicians and global health experts are expected to attend. For more information view https://www.astmh.org/

If you are not able to join us in-person then why not follow what is happening at the conference over Twitter by following us on @IDDOnews

Read our latest news or email info@iddo.org with your questions.